Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer Mar 6, 2022 | Triple Negative Breast Cancer
A deep learning-based iterative digital pathology annotation tool Aug 24, 2021 | Non-Small Cell Lung Cancer, Triple Negative Breast Cancer
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations May 20, 2020 | Non-Small Cell Lung Cancer, Triple Negative Breast Cancer
Overcoming hypoxia-induced functional suppression of NK cells Apr 8, 2020 | Non-Small Cell Lung Cancer, Triple Negative Breast Cancer
NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly-Informed Integrated Immunotherapy Combining Innate High-Affinity Natural Killer (haNK) Cell Therapy with Adenoviral & Yeast-based Vaccines and Immune Checkpoint Inhibitor to Induce T-Cell Responses in Subjects with TNBC Who Have Progressed on or after Standard-of-Care Therapy Dec 11, 2019 | Triple Negative Breast Cancer
Innate and adaptive immunotherapy: An orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T-cell therapy in patients with third line or greater Triple-Negative Breast Cancer (TNBC) May 26, 2019 | Triple Negative Breast Cancer
